CNBC Daily Open: All that glitters is gold — and bitcoin
U.S. equity markets have received the lion’s share of attention over the past five weeks, but now investors seem to be captivated by the new and shiny.
Sec. Gina Raimondo: Threat from China is large and growing, can’t let it access top tier AI chips
Secretary of Commerce Gina Raimondo sat down with CNBC’s Morgan Brennan over the weekend to discuss semiconductor trade with China and how U.S. policy is impacting chip makers.
Former U.S. ambassador spied for Cuba for decades, Justice Department says
Attorney General Merrick Garland called it “one of the highest-reaching and longest-lasting infiltrations of the United States government by a foreign agent.”
Gen Z women spend more on TikTok as app ‘drives consumption,’ analyst says
Gen Z women are driving spending trends on TikTok with the most time viewing short-form videos on the app and exposure to influencer advertising.
Stocks making the biggest moves midday: Spotify, Virgin Galactic, Lululemon and more
These are the stocks posting the largest moves in midday trading.
Buy these stocks with high dividend growth and free cash flow yield, Wolfe says
This strategy performs very well in later cycle/recessionary environments, according to Wolfe Research.
Uber shares pop as company is slated to join S&P 500
The S&P Dow Jones Indices announced Friday that Uber has been selected to join the S&P 500 Index.
China’s emissions targets not robust enough, U.S. energy chief says
The U.S. and China need to “raise both of our levels of ambition, because we’re the two biggest economies and the two biggest emitters,” David Turk told CNBC.
Roche enters obesity market with Carmot takeover but drugs may not be available until 2030
Roche is to acquire anti obesity drug developer Carmot Therapeutics, becoming the latest pharma company to enter the global weight-loss drugs market.
